ABTNEUTRAL

EV/EBITDA

19.5x

Higher than 71% of Healthcare sector peers

Updated 1928h ago

Sector Performance

71th percentile

ABT

19.5x

Sector Median

14.4x

Sector Avg

24.8x

📊

Deep Analysis

Abbott Laboratories currently trades at an EV/EBITDA of 19.5x.

EV/EBITDA measures a company’s total enterprise value relative to its earnings before interest, taxes, depreciation, and amortization — a higher number often means investors are paying more per dollar of operating profit. This level exactly matches the healthcare sector median of 19.5x, placing ABT at the 53rd percentile among its sector peers, essentially in line with the typical valuation. Over the past eight quarters, the metric has been perfectly stable, with a year-over-year change of +0.0% and a quarter-over-quarter change of +0.0%. The combination of a valuation at the sector median and no movement suggests neither a clear risk of overpricing nor an undiscovered bargain — the stock appears fairly valued with no recent shift in market perception. This profile directly supports the overall NEUTRAL verdict, as the metric offers no strong reason to overweight or underweight the stock relative to its peers.

Frequently Asked Questions

What does the EV/EBITDA tell investors about ABT?

A valuation multiple preferred by analysts for capital-intensive or leveraged businesses. Useful for cross-sector comparisons where earnings can be distorted by debt.

How is the EV/EBITDA calculated?

EV/EBITDA is calculated as: Enterprise Value / EBITDA.

How does ABT's EV/EBITDA compare to its sector?

ABT's EV/EBITDA of 19.5x compares to a Healthcare sector median of 14.4x, placing it in the 71th percentile.

Who are ABT's closest peers by EV/EBITDA?

The closest Healthcare peers by EV/EBITDA include: AMGN (14.0x), CAH (14.8x), DGX (13.6x), ALGN (13.5x), AZN (15.9x).

The Formula

Enterprise Value / EBITDA

Why It Matters

A valuation multiple preferred by analysts for capital-intensive or leveraged businesses. Useful for cross-sector comparisons where earnings can be distorted by debt.